Cathy Friedman - Net Worth and Insider Trading

Cathy Friedman Net Worth

The estimated net worth of Cathy Friedman is at least $9 Million dollars as of 2024-04-24. Cathy Friedman is the Director of Lyell Immunopharma Inc and owns about 3,883,490 shares of Lyell Immunopharma Inc (LYEL) stock worth over $9 Million. Details can be seen in Cathy Friedman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cathy Friedman has not made any transactions after 2021-06-21 and currently still holds the listed stock(s).

Transaction Summary of Cathy Friedman

To

Cathy Friedman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cathy Friedman owns 10 companies in total, including Radius Health Inc (RDUS) , Altaba Inc (AABA) , and Innoviva Inc (INVA) among others .

Click here to see the complete history of Cathy Friedman’s form 4 insider trades.

Insider Ownership Summary of Cathy Friedman

Ticker Comapny Transaction Date Type of Owner
RDUS Radius Health Inc 2022-08-15 director
AABA Altaba Inc 2017-06-13 director
INVA Innoviva Inc 2014-12-22 director
XNPT XenoPort Inc 2016-07-05 director
RSLS Reshape Lifesciences Inc 2015-05-06 director
SSSS SuRo Capital Corp 2013-03-08 director
SEER Seer Inc 2021-06-17 director
LYEL Lyell Immunopharma Inc 2021-06-21 director
REVHU Revolution Healthcare Acquisition Corp 2021-03-17 director
REVH Revolution Healthcare Acquisition Corp 2021-03-17 director

Cathy Friedman Latest Holdings Summary

Cathy Friedman currently owns a total of 1 stock. Cathy Friedman owns 3,883,490 shares of Lyell Immunopharma Inc (LYEL) as of June 21, 2021, with a value of $9 Million.

Latest Holdings of Cathy Friedman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LYEL Lyell Immunopharma Inc 2021-06-21 3,883,490 2.44 9,475,716

Holding Weightings of Cathy Friedman


Cathy Friedman Form 4 Trading Tracker

According to the SEC Form 4 filings, Cathy Friedman has made a total of 1 transactions in Lyell Immunopharma Inc (LYEL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lyell Immunopharma Inc is the acquisition of 17,648 shares on June 21, 2021, which cost Cathy Friedman around $300,016.

Insider Trading History of Cathy Friedman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cathy Friedman Trading Performance

GuruFocus tracks the stock performance after each of Cathy Friedman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cathy Friedman is -33.97%. GuruFocus also compares Cathy Friedman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cathy Friedman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cathy Friedman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cathy Friedman

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.76 -33.97 -55.58 -65.67 -56.24
Relative Return to S&P 500(%) -8.93 -37.03 -65.63 -54.78 -57.89

Cathy Friedman Ownership Network

Ownership Network List of Cathy Friedman

No Data

Ownership Network Relation of Cathy Friedman


Cathy Friedman Owned Company Details

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Cathy Friedman is the director of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Radius Health Inc Insider Transactions

No Available Data

Cathy Friedman Mailing Address

Above is the net worth, insider trading, and ownership report for Cathy Friedman. You might contact Cathy Friedman via mailing address: C/o Innoviva, Inc., 2000 Sierra Point Parkway, Suite 500, Brisbane Ca 94005.

Discussions on Cathy Friedman

No discussions yet.